Awaiting connection
Telegram
Quick product questions and source links in a Telegram bot conversation.
Open Telegram
VELYRA INTELLIGENCE RESEARCH USE ONLY
Peptides,
explained.
Ask Velyra Agent to compare peptide forms, explain the research, and show where the evidence stops.
Velyra Agent
PEPTIDE RESEARCH DESK
Knowledge-base preview · Laboratory research only
01 / MESSAGING
Take the chat
with you.
Ask from the web today. Telegram and WhatsApp are the next channels for the same product questions.
Awaiting connection
Ask about the lineup and compare entries in a WhatsApp Business chat.
Open WhatsApp02 / THE LINEUP
The peptide index.
Browse the lineup by category and compare the forms listed for each entry.
FIG. 01
Research only
BPC-157
FIG. 02
Research only
TB-500
FIG. 03
Research only
MOTS-c
FIG. 04
Research only
Epitalon
FIG. 05
Research only
Oral BPC
FIG. 06
Research only
Semax Nasal Spray
For laboratory research use only. Never administer to humans or animals. Packaging is illustrative, and categories organize the research catalog.
03 / FOR YOUR AGENT
Connect to
the catalog.
Give an MCP-compatible agent read access to the same product entries, evidence notes, source links, and FAQs used by Velyra.
Access follows your Velyra site permissions.
VELYRA / MCPREAD ONLY
/mcp- list_peptides
- Browse or filter the lineup
- get_peptide
- Read an entry and its source
- compare_peptides
- Compare forms and evidence
- list_faqs
- Look up catalog FAQs
04 / FIELD NOTES
Common
questions.
01 What are peptides?
Peptides are short chains of amino acids, the building blocks of proteins. Each peptide has its own properties and evidence base.
02 What do the categories mean?
Recovery, metabolism, longevity, and brain health are browsing categories. A category label does not establish that a peptide is effective for that purpose.
03 Which forms are in the index?
The index lists four injection entries, one pill entry, and one nasal spray entry. The form appears on each entry’s card.
04 Can I order from Velyra?
Velyra’s current site is a research catalog. There are no published Velyra prices, ordering, shipping, refunds or membership terms for these entries.
05 How does U.S. compounding policy differ from FDA approval?
In October 2026, U.S. HHS described conditions for enforcement discretion under section 503A for BPC-157, TB-500, MOTS-c, epitalon, Semax and KPV. Only specified ingredient forms and routes are covered. KPV is outside the Velyra catalog. This interim policy may change. It does not confer FDA approval or establish that a finished product is safe, effective or available.
HHS interim 503A peptide compounding policy, October 2026 FDA questions and answers about compounding
06 What can a certificate of analysis tell me?
A lot-specific certificate of analysis records tests for the ingredient’s identity, potency, impurities and relevant contaminants. The HHS policy also addresses traceability to the original manufacturer. Ingredient testing and facility registration alone do not verify a finished product. Velyra’s catalog does not publish batch certificates for these entries.
HHS interim 503A peptide compounding policy, October 2026 FDA questions and answers about compounding
07 How does prescription compounding differ from research use?
The U.S. 503A framework includes patient-specific prescription requirements for eligible compounded drugs. Velyra’s research catalog is a separate resource for laboratory research. A discussion of prescription compounding does not make any Velyra material suitable for administration.
HHS interim 503A peptide compounding policy, October 2026 FDA questions and answers about compounding
08 How are follow-up findings interpreted in published studies?
A study may track symptoms, lab measurements and adverse events. Its design, duration and population affect what those observations can tell us. A change in a lab marker alone does not establish a clinical benefit.
09 How are peptide blends different from individual entries?
BPC-157 and TB-500 are separate catalog entries. Evidence for a single ingredient does not establish the safety or effectiveness of a blend. The October 2026 HHS interim policy applies to eligible compounded preparations with one listed active ingredient.
10 What does “research use only” mean?
Velyra entries are for laboratory research only. Human and veterinary administration, diagnosis and treatment are prohibited. The research label also does not verify a material’s identity, purity or sterility.
HHS interim 503A peptide compounding policy, October 2026 FDA questions and answers about compounding
11 What should competitive athletes know about these entries?
The 2026 WADA list names BPC-157 under S0, TB-500 under S2, and MOTS-c under S4. All three are prohibited at all times under that list. Athletes should check the current rules with their sport’s anti-doping authority for the exact substance and formulation.